Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 15/20 | 0.71 |
| ▸ | NTRK1 | P04629 | 7/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15840798 | 0.87 | IGF1R (0.67) | IGF1RNTRK1 | |
| SCHEMBL29794741 | 0.83 | NTRK1 (0.79) | IGF1RNTRK1 | |
| SCHEMBL4064474 | 0.83 | NTRK1 (0.79) | IGF1RNTRK1 | |
| SCHEMBL4075877 | 0.83 | IGF1R (1.00) | IGF1RNTRK1 | |
| SCHEMBL4072338 | 0.83 | NTRK1 (0.79) | IGF1RNTRK1 | |
| SCHEMBL3338062 | 0.83 | NTRK1 (0.79) | IGF1RNTRK1 | |
| SCHEMBL4069157 | 0.83 | IGF1R (1.00) | IGF1RNTRK1 | |
| SCHEMBL4459019 | 0.83 | IGF1R (1.00) | IGF1RNTRK1 | |
| SCHEMBL29794579 | 0.83 | IGF1R (1.00) | IGF1RNTRK1 | |
| SCHEMBL15109539 | 0.82 | IGF1R (0.78) | IGF1RNTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179664-A1 | Heterocyclyl Pyrimidine Analogues As JAK Inhibitors | CELLZOME LIMITED (GB) | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179664-A1 | Heterocyclyl Pyrimidine Analogues As JAK Inhibitors | JAK1, JAK3, JAK2 | IGF1R 1826/4885NTRK1 4690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.